C. Diff Infection Study in Babies
Part of Infections clinical trials.
This study looks at Clostridium difficile (C. diff) infections in babies under 2. It compares babies who have the infection with those who don't, using medical records to learn more about how it affects them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be between 0 and 2 years old.
- They either have a confirmed Clostridium difficile (C. diff) infection, or they don't (to serve as a comparison).
- Their medical records must be complete, including feeding history and antibiotic use.
- They cannot have other serious stomach or bowel conditions that could confuse the results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at C. difficile bacteria in babies up to 2 years old. It compares babies with C. difficile infection, carriers without symptoms, and healthy babies to understand how the bacteria affects them.
This trial tests a new treatment called CMTS0929 for people with C. diff infection. It aims to see if the treatment can help clear the infection and improve symptoms.
This trial tests a treatment called washed microbiota transplantation (WMT) for people with a C. diff infection that causes diarrhea. WMT uses processed donor bacteria to help restore healthy gut balance and fight the infection.
This study looks at children with ongoing diarrhea to better understand the causes and find better ways to diagnose and treat it. It will use advanced testing to learn more about the condition.
This study follows pregnant women and their newborns to understand how a bacterium called Clostridioides difficile (C. difficile) colonizes and leaves the digestive tract in infants. Researchers want to identify factors that influence this process to better understand infant gut health and infection risk.
This trial studies how Clostridioides difficile (C. diff) affects healthy people by intentionally giving a controlled dose. The goal is to understand the infection better and help develop future treatments or vaccines.
Hear when a new Clostridium Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.